U.S. market Closed. Opens in 11 hours 35 minutes

NAUT | Nautilus Biotechnology, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/AN/AN/AN/AN/A
Cost of Revenue5.71M3.42M2.84M2.35MN/AN/A
Gross Profit-5.71M-3.42M-2.84M-2.35MN/AN/A
Operating Expenses70.45M63.62M50.50M15.74M9.62K111.68M
Selling, General & Admin25.05M25.95M21.15M3.31M1.62K111.68M
Research & Development45.40M37.67M29.35M12.43M8.49KN/A
Other Operating ExpensesN/A-122.00K183.00K125.00KN/AN/A
Operating Income-76.15M-63.62M-50.50M-15.74M-10.11K-111.68M
Other Expenses / Income12.48M5.69M183.00K125.00K492.00738.28M
Before Tax Income-63.67M-57.92M-50.31M-15.62M-9.62K626.60M
Income Tax ExpensesN/A5.82M2.61M2.14M-171.31KN/A
Net Income-63.67M-63.74M-50.31M-15.62M-9.62K626.60M
Interest ExpensesN/A5.82MN/AN/AN/AN/A
Basic Shares Outstanding124.92M124.59M84.46M29.96M7.19M14.38M
Diluted Shares Outstanding124.92M124.59M84.46M29.96M7.19M14.38M
EBITDA-70.45M-60.20M-47.66M-13.40M-9.56K626.60M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-63.67M-52.11M-47.71M-13.48M-180.93K626.60M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙